Nkarta is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies to treat cancer. Nkarta seeks to improve upon the efficacy of cell therapy, making it more potent, better tolerated and more rapidly available to a broad population of patients with a variety of hematologic and solid tumor malignancies.
More information is coming soon.
Data Provided by Refinitiv. Minimum 15 minutes delayed.
Nov 12, 2021
Nov 10, 2021
Nov 04, 2021